Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.

Martin A, Tope WD, Grevelink JM, Starr JC, Fewkes JL, Flotte TJ, Deutsch TF, Anderson RR.

Arch Dermatol Res. 1995;287(7):665-74.

PMID:
8534131
2.

5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM.

Cancer. 1997 Jun 15;79(12):2282-308. Review.

PMID:
9191516
3.

Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.

Fujita AK, Rodrigues PG, Requena MB, Escobar A, da Rocha RW, Nardi AB, Kurachi C, de Menezes PF, Bagnato VS.

Photodiagnosis Photodyn Ther. 2016 Sep;15:236-44. doi: 10.1016/j.pdpdt.2016.05.008. Epub 2016 Jun 7. Review.

PMID:
27288253
4.

Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.

Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, Shulman DG.

J Clin Laser Med Surg. 1996 Apr;14(2):59-66. Review.

PMID:
9484077
5.

Fluorescence-guided resection of brain tumor: review of the significance of intraoperative quantification of protoporphyrin IX fluorescence.

Huang Z, Shi S, Qiu H, Li D, Zou J, Hu S.

Neurophotonics. 2017 Jan;4(1):011011. doi: 10.1117/1.NPh.4.1.011011. Epub 2017 Jan 12. Review.

PMID:
28097209

Supplemental Content

Support Center